Your browser doesn't support javascript.
loading
Basaloid squamous cell carcinoma of the larynx: A rare case report.
Al-Janabi, Moatasem Ali Hussein; Mousto, Reham; Abodest, Riham; Tally, Hanan; Daoud, Ali Kamel; Ibrahim, Mostafa.
Afiliação
  • Al-Janabi MAH; Department of Pathology, Cancer Research Center, Tishreen University Hospital, Lattakia, Syria. Electronic address: dr.3esami2022@gmail.com.
  • Mousto R; Faculty of Medicine, Tishreen University, Lattakia, Syria.
  • Abodest R; Faculty of Medicine, Tishreen University, Lattakia, Syria.
  • Tally H; Department of ENT, Tishreen University Hospital, Lattakia, Syria.
  • Daoud AK; Department of Pathology, Tishreen University Hospital, Lattakia, Syria.
  • Ibrahim M; Department of ENT, Tishreen University Hospital, Lattakia, Syria.
Int J Surg Case Rep ; 111: 108791, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37690277
ABSTRACT
INTRODUCTION AND IMPORTANCE Basaloid squamous cell carcinoma (BSCC) is a rare and aggressive subtype of squamous cell carcinoma. BSCC in the larynx is an extremely rare occurrence, with only a few cases reported in the medical literature. This case report aims to shed light on the clinical presentation, diagnostic challenges, histopathological features, and therapeutic considerations associated with this rare entity. CASE PRESENTATION This case report describes a 65-year-old male patient who presented with hoarseness and dyspnea. Laryngoscopy revealed a 2.5 cm pedunculated lesion on the left vocal cord. The patient underwent a laryngectomy, and the histopathological examination of the excised specimen confirmed the diagnosis of BSCC. CLINICAL

DISCUSSION:

BSCC of the larynx is a rare malignancy comprising less than 1 % of laryngeal cancers. Clinical features often overlap those of squamous cell carcinoma, such as hoarseness, progressive breathing difficulties, and swallowing issues. Treatment approaches vary, with some opting for neo-adjuvant radiotherapy before surgery, like in this case, while others favor surgical excision as the primary treatment, supplemented by adjuvant chemo- or radiotherapy in certain cases.

CONCLUSION:

Basaloid squamous cell carcinoma is a rare variant of squamous cell carcinoma. Clinicians and pathologists should be aware of the distinctive characteristics of BSCC and its potential clinical aggressiveness. While rare, early recognition and appropriate management are essential for achieving favorable outcomes in patients with this challenging condition.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article